Skip to content
Menu

Barclays Upgrades Astrana Health to Overweight, Raises Price Target to $50

Benzinga Newsdesk 5 months ago

NewsUpgradesPrice TargetAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.

Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.

Read at benzinga.com